FTC says Danaher Corporation’s acquisition of GE Biopharma anticompetitiveChristian Fernsby ▼ | May 30, 2020
The Federal Trade Commission has approved a final order settling charges that Danaher Corporation’s acquisition of GE Biopharma would likely reduce competition in highly concentrated markets that supply biopharmaceutical companies with key inputs.
GE Biopharma Danaher Corporation
Topics: FTC Danaher Corporation GE Biopharma
The products to be divested include: microcarrier beads, conventional low-pressure liquid chromatography columns, conventional low-pressure liquid chromatography skids, single-use low pressure liquid chromatography skids, chromatography resins, low-pressure liquid chromatography continuous chromatography systems, single-use tangential flow filtration systems, and label-free molecular characterization instruments. ■